Briefing: Failing to succeed: Why post‑secondary students need more room to mess up
Strategic angle: University students today face a confusing mix of messages about failure, navigating systems that often penalize mistakes.
Briefing: How To Manage Royal Caribbean Stock Amid High Oil Prices
Strategic angle: Strategies for navigating Royal Caribbean's stock performance in a volatile oil market.
Hyundai Stops Palisade Sales, Recalls 68,500 SUVs After Fatal Incident
Hyundai is urging owners to use caution when operating the SUV's second- and third-row power seats.
Briefing: A brain-computer interface allowed people with paralysis to type with their mind
Strategic angle: Two people with paralysis were able to type using a brain-computer interface that decodes attempted finger movement, a new study showed.
Briefing: Peloton is launching bikes and treadmills for gyms, accelerating commercial strategy
Strategic angle: Peloton is launching commercial gym-ready Bikes and Treads, expanding into gyms globally as it seeks new growth beyond its at-home fitness business.
Briefing: The Volvo EX30 Joins America's EV Graveyard
Strategic angle: It's the end of the road for Volvo's smallest and cheapest electric car. The larger EX60 is still on the way though.
Briefing: The seven hour explosion nobody could explain
Strategic angle: Gamma-ray bursts are the most violent explosions in the universe, releasing immense energy in a fraction of a second.
Briefing: FTC Tells Almost 100 Dealer Groups Their “Great Price” Needs To Be The Real Price
Strategic angle: The agency says car ads should show the actual price buyers pay, not a teaser price that grows significantly with hidden fees at signing time.
Briefing: Truckload linehaul rate index nears 3-year high in February
Strategic angle: Truckload linehaul rate index approaches its highest point in three years, signaling potential changes in the freight market.
Briefing: What is HELIOS, the US laser destroying cheap Iranian drones for cents
Strategic angle: The High Energy Laser with Integrated Optical-dazzler and Surveillance, deployed on a US naval ship, downed several drones last week. Here’s what you need to know about the game-changing technology.
Briefing: Durbin and Raskin call for perjury investigation into DHS' Kristi Noem
Strategic angle: Ousted Homeland Security Secretary Kristi Noem testified before Congress earlier this month.
Briefing: Birthright Citizenship: A Response to Pete Patterson
Strategic angle: Exploring the implications of birthright citizenship through a constitutional lens.
Briefing: Oldest known whale recording could unlock mysteries of the ocean
Strategic angle: A haunting whale song discovered on decades-old audio equipment could open up a new understanding of how the huge animals communicate.
Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4
Emerald Growth Equity Strategy has divested from Revvity (RVTY) in the fourth quarter.
Briefing: Using options to play a long-term shift into nuclear energy resulting from Mideast war
Strategic angle: Exploring investment strategies in nuclear energy amid geopolitical tensions.
Briefing: Alphabet (GOOG) is Gaining from Double Tailwinds
Strategic angle: Alphabet's growth is being propelled by two significant factors.
Briefing: He manages the best-performing stock mutual fund of the past 25 years—here's his top advice for investors
Strategic angle: Michael Lippert runs Baron Opportunity, a mutual fund which aims to invest in fast-growing stocks benefitting from technological trends.
Briefing: US Home Builder Sentiment Edges Up in March - NAHB
Strategic angle: A slight increase in home builder sentiment indicates a potential recovery in the housing market.
Briefing: A 95th birthday tribute to legendary SCOTUSblog reporter Lyle Denniston
Strategic angle: The inimitable Lyle Denniston, who served as the primary reporter for SCOTUSblog from 2004 until 2016, celebrates his 95th birthday today.
Briefing: STAT+: Two more drugmakers join TrumpRx
Strategic angle: Medicare delays stall breakthrough device access, ALS carriers fear research setbacks under Trump, and more biotech news